These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 12537979)
1. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL). Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells. Yang B; Fan L; Fang L; He Q Cancer Chemother Pharmacol; 2006 Oct; 58(4):540-6. PubMed ID: 16520989 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation. Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104 [TBL] [Abstract][Full Text] [Related]
4. Fenretinide activates caspases and induces apoptosis in gliomas. Puduvalli VK; Saito Y; Xu R; Kouraklis GP; Levin VA; Kyritsis AP Clin Cancer Res; 1999 Aug; 5(8):2230-5. PubMed ID: 10473110 [TBL] [Abstract][Full Text] [Related]
5. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Delia D; Aiello A; Formelli F; Fontanella E; Costa A; Miyashita T; Reed JC; Pierotti MA Blood; 1995 Jan; 85(2):359-67. PubMed ID: 7811993 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells. Shan D; Gopal AK; Press OW Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide. Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458 [TBL] [Abstract][Full Text] [Related]
8. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy? Ohlmann CH; Jung C; Jaques G Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800 [TBL] [Abstract][Full Text] [Related]
9. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815 [TBL] [Abstract][Full Text] [Related]
10. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells. Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286 [TBL] [Abstract][Full Text] [Related]
11. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155 [TBL] [Abstract][Full Text] [Related]
12. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines. Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096 [TBL] [Abstract][Full Text] [Related]
14. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676 [TBL] [Abstract][Full Text] [Related]
15. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action. Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489 [TBL] [Abstract][Full Text] [Related]
16. N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes. O'Donnell PH; Guo WX; Reynolds CP; Maurer BJ Leukemia; 2002 May; 16(5):902-10. PubMed ID: 11986953 [TBL] [Abstract][Full Text] [Related]
17. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer. Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982 [TBL] [Abstract][Full Text] [Related]
18. N-(4-hydroxyphenyl)retinamide induces apoptosis in T lymphoma and T lymphoblastoid leukemia cells. Chan LN; Zhang S; Shao J; Waikel R; Thompson EA; Chan TS Leuk Lymphoma; 1997 Apr; 25(3-4):271-80. PubMed ID: 9168437 [TBL] [Abstract][Full Text] [Related]
19. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722 [TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of fenretinide-triggered apoptosis in leukemic cells]. Xiao DK; Du YZ; Fan HY; Chen YL; Chen Z; Zhang J; Wang KK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):975-8. PubMed ID: 16403262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]